LXRX. Approved Drug. More coming.

NASDAQ:LXRX   Lexicon Pharmaceuticals, Inc.
LXRX. Approved Drug. More drugs coming to market. Selling new drug starts in June.
High institutional value. High Insider Value. etc etc
Rocket is fueling.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.